In a major breakthrough for male contraception, the first human safety trial of the hormone-free birth control pill YCT-529 has shown promising results. Developed by YourChoice Therapeutics in collaboration with Columbia University and the University of Minnesota, the experimental pill successfully completed phase 1 testing.